Troy Morgan, JD

Mr. Morgan is senior vice president, chief compliance officer, with responsibility for overseeing the strategic direction of the company’s comprehensive compliance program and to help ensure all global compliance requirements are met across the organization. Prior to joining Novavax in April 2021, he was chief compliance officer for EMD Serono, Inc., where he was responsible for building a global corporate compliance program that supported a broad range of therapies. Previously, he served in senior leadership roles at Merck KGaA, Sanofi, Biogen and at Bioverativ, where he was responsible for the development, implementation and management of a global compliance program. Mr. Morgan holds a Master of Laws from Pepperdine University, a Juris Doctorate from Faulkner University’s Jones School of Law, and a Bachelor of Science from Troy State University.